Cross-reactivity of cryptococcal antigen lateral flow assay with basidiomycetous yeasts

Sarah E Kidd1,2, Catriona L Halliday3,4

  • 1National Mycology Reference Centre, SA Pathology, Adelaide, South Australia 5000, Australia.

Medical Mycology
|June 30, 2026
PubMed

Insights

The cryptococcal antigen lateral flow assay (CrAg LFA) can cross-react with other fungi. This study found positive CrAg LFA results for several basidiomycetous yeasts, not just Cryptococcus species.

Area of Science:

  • Mycology
  • Clinical Diagnostics
  • Infectious Diseases

Background:

  • The cryptococcal antigen lateral flow assay (CrAg LFA) is a key diagnostic tool for cryptococcal meningitis.
  • Previous reports suggest potential cross-reactivity of CrAg LFA with certain yeast species.
  • The scope of this cross-reactivity within basidiomycetous yeasts remains incompletely understood.

Purpose of the Study:

  • To investigate the extent of cross-reactivity of the CrAg LFA with a diverse panel of basidiomycetous yeast isolates.
  • To identify specific basidiomycetous yeast species that may yield false-positive results with the CrAg LFA.

Main Methods:

  • A collection of basidiomycetous yeast isolates from various genera were tested using a commercially available CrAg LFA.
  • Isolates included species from genera such as Trichosporon, Naganishia, Cutaneotrichosporon, Filobasidium, and Ustilago.
  • Results were analyzed to determine which species exhibited positive reactions with the assay.

Main Results:

  • All tested isolates belonging to the genera Trichosporon and Naganishia showed positive reactions.
  • Positive results were also observed in some isolates from the genera Cutaneotrichosporon, Filobasidium, and Ustilago.
  • No cross-reactivity was noted with other tested basidiomycetous yeasts.

Conclusions:

  • The CrAg LFA demonstrates cross-reactivity with multiple basidiomycetous yeast species beyond Cryptococcus.
  • Clinicians should be aware of potential false-positive CrAg LFA results in the presence of these yeasts, although they rarely cause invasive infections.
  • Further investigation may be warranted to understand the clinical implications of this cross-reactivity.

Related Concept Videos